Inovio Pharmaceuticals Selected by DARPA to Lead a $45 Million Program to Expedite Development of Novel Products to Prevent and Treat Disease Caused by Ebola
April 08, 2015 06:00 ET
|
Inovio Pharmaceuticals, Inc.
PLYMOUTH MEETING, Pa., April 8, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that the company has been selected to receive a grant from the Defense Advanced...
Inovio Pharmaceuticals to Present at Alliance Regenerative Medicine's 2015 Regen Med Investor Day
March 19, 2015 08:00 ET
|
Inovio Pharmaceuticals, Inc.
PLYMOUTH MEETING, Pa., March 19, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that Chief Operating Officer, Dr. Niranjan Sardesai, will present at the 3rd Annual...
Inovio Pharmaceuticals Appoints Scott M. White, M.D. Vice President, Clinical Development -- Infectious Diseases
March 18, 2015 08:00 ET
|
Inovio Pharmaceuticals, Inc.
PLYMOUTH MEETING, Pa., March 18, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today the appointment of Scott M. White, M.D. as Vice President, Clinical Development...
Inovio Pharmaceuticals and Academic Collaborators Receive $16 Million HIV Grant From National Institute of Allergy and Infectious Diseases
March 16, 2015 08:00 ET
|
Inovio Pharmaceuticals, Inc.
PLYMOUTH MEETING, Pa., March 16, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that the company and its academic collaborators, including the University of...
Inovio Pharmaceuticals Reports 2014 Fourth Quarter and Year End Financial Results
March 16, 2015 06:30 ET
|
Inovio Pharmaceuticals, Inc.
PLYMOUTH MEETING, Pa., March 16, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) today reported financial results for the fourth quarter and year ended December 31, 2014.
Total...
Inovio Pharmaceuticals to Report Fourth Quarter and Year End 2014 Financial Results on March 16, 2015
March 06, 2015 08:30 ET
|
Inovio Pharmaceuticals, Inc.
PLYMOUTH MEETING, Pa., March 6, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that it will host a conference call and live webcast to report its 2014 fourth...
Inovio Pharmaceuticals Welcomes Nancy Wysenski to Its Board of Directors
March 05, 2015 08:46 ET
|
Inovio Pharmaceuticals, Inc.
PLYMOUTH MEETING, Pa., March 5, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO), a leader in the development of immunotherapies for cancer and infectious diseases, announced today...
Inovio Pharmaceuticals to Present at Upcoming Investor Conferences
February 02, 2015 08:00 ET
|
Inovio Pharmaceuticals, Inc.
PLYMOUTH MEETING, Pa., Feb. 2, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that President and CEO, Dr. J. Joseph Kim, will present a corporate overview at the...